In contrast, among the genes suppressed in BTCs were epithelial markers previously described in the “luminal” subtypes of bladder cancer (e.g. CDH1, E-cadherin; ERBB2, receptor tyrosine kinase 2, a known oncogene)9. This evidence concerns the gene ERBB2 and urinary bladder carcinoma.